CVE-2024-1629

Exploitation

Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.

SSVC decision

• ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
• AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
• Technical ImpactpartialSuccessful exploitation gives limited control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

0.28% probability of exploitation activity in the next 30 days.

EPSS percentile

Equal to or higher than the score of 20.6% of scored records. A rank, not a probability.

NVD base score

6.2 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

NVD analysis status

Deferred. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2024-05-14 16:32Z2 YR AGO

Last updated

2024-08-01 18:48Z2 YR AGO

Reserved

2024-02-19

Assigning CNA

GEHC

Record state

PUBLISHED

Severity

Medium (CVSS 6.2)

CNA CVSS vector

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Weaknesses

• CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')Base

Data version

5.1

Document digest

7f699c2a337c2995f11ad0444d32b9e09e9863a0f93219aa466592bb2e99a12b

• securityupdate.gehealthcare.comhttps://securityupdate.gehealthcare.com/